ATB Therapeutics
PrivateLast Round
Series A
Nov 18, 2024
Total Funding Raised
$62.6M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
ATB Therapeutics is a biotechnology company that develops a new class of antibody-based targeted therapies, called atbodies, to treat cancer and autoimmune diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ATB Therapeutics Comparables
Compare ATB Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Sutro Biopharma Inc | 72% | |
| Mersana Therapeutics | 69% | |
| Pfizer | 68% | |
ATB Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Nov 18, 2024 | ||||
| Seed | Dec 23, 2019 | ||||
| Seed | Jan 1, 2018 |
Key People
Founding team and executive leadership
ATB Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Federal Holding and Investment Company | Series A |
| EQT Life Sciences | Series A |
| Noshaq | Seed |
| Wallonie Entreprendre | Series A |
| V-Bio Ventures | Series A |
| VIVES Partners | Series A |
| Financière Spin-off Luxembourgeoise | Seed, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 24, 2026
Monthly visitors grew 122% MoM, from 522 to 1.2K.
- Nov 18, 2024
Raised $57M in Series A funding.
ATB Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about ATB Therapeutics's valuation, stock price, and market status.